Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
01 1Aarti Pharmalabs Limited
02 1Apicore Pharmaceuticals Private Limited
03 1Emcure Pharmaceuticals Limited
01 1DIFLUNISAL
02 1Diflunisal
03 1diflunisal
01 3India
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
NDC Package Code : 15308-0811
Start Marketing Date : 2012-04-08
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42973-152
Start Marketing Date : 2008-11-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14593-891
Start Marketing Date : 2022-02-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (15kg/15kg)
Marketing Category : BULK INGREDIENT
A Diflunisal manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diflunisal, including repackagers and relabelers. The FDA regulates Diflunisal manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diflunisal API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Diflunisal manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Diflunisal supplier is an individual or a company that provides Diflunisal active pharmaceutical ingredient (API) or Diflunisal finished formulations upon request. The Diflunisal suppliers may include Diflunisal API manufacturers, exporters, distributors and traders.
click here to find a list of Diflunisal suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Diflunisal as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Diflunisal API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Diflunisal as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Diflunisal and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Diflunisal NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Diflunisal suppliers with NDC on PharmaCompass.
We have 3 companies offering Diflunisal
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
